Carlyle Group LP is lining up a USD 3.7 billion debt financing for the purchase of Ortho Clinical Diagnostics Inc, the diagnostics arm of Johnson & Johnson. Barclays Plc and Goldman Sachs Group Inc. are leading the deal, which includes USD 2.15 billion in term loans, USD 1.15 billion in bonds as well as a revolving credit of up to USD 400 million. The takeover was seen to be inked by the end of a week, unless delayed due to ongoing talks.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.47 USD | -2.24% | +9.57% | +11.75% |
07-17 | Discover Financial quarterly profit jumps on higher interest income | RE |
07-17 | KKR: invests with Carlyle in student loans | CF |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+11.75% | 16.36B | |
+3.00% | 102B | |
+37.33% | 101B | |
+20.85% | 28.68B | |
-9.60% | 17.41B | |
+6.66% | 14.61B | |
-20.04% | 12.53B | |
+28.24% | 10.44B | |
+26.04% | 9.78B | |
+21.27% | 6.8B |
- Stock Market
- Equities
- CG Stock
- News The Carlyle Group Inc.
- Carlyle Group LP to Line Up USD 3.7 Billion Debt Financing for the Purchase of Ortho Clinical Diagnostics Inc